The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy
Bal C, Korn S, Milger-Kneidinger K, Skowasch D, Schulz C, Zehetmayer S, Taube C, Hamelmann E, Buhl R, Idzko M (2023)
Pneumologie 77(S 01): S45.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Bal, C.;
Korn, S.;
Milger-Kneidinger, K.;
Skowasch, D.;
Schulz, C.;
Zehetmayer, S.;
Taube, C.;
Hamelmann, EckardUniBi;
Buhl, R.;
Idzko, M.
Erscheinungsjahr
2023
Serien- oder Zeitschriftentitel
Pneumologie
Band
77
Ausgabe
S 01
Seite(n)
S45
ISSN
0934-8387
eISSN
1438-8790
Page URI
https://pub.uni-bielefeld.de/record/2980002
Zitieren
Bal C, Korn S, Milger-Kneidinger K, et al. The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy. Pneumologie. 2023;77(S 01):S45.
Bal, C., Korn, S., Milger-Kneidinger, K., Skowasch, D., Schulz, C., Zehetmayer, S., Taube, C., et al. (2023). The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy. Pneumologie, 77(S 01), S45. https://doi.org/10.1055/s-0043-1760974
Bal, C., Korn, S., Milger-Kneidinger, K., Skowasch, D., Schulz, C., Zehetmayer, S., Taube, C., Hamelmann, Eckard, Buhl, R., and Idzko, M. 2023. “The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy”, Pneumologie, 77 (S 01): S45.
Bal, C., Korn, S., Milger-Kneidinger, K., Skowasch, D., Schulz, C., Zehetmayer, S., Taube, C., Hamelmann, E., Buhl, R., and Idzko, M. (2023). The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy. Pneumologie 77, S45.
Bal, C., et al., 2023. The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy. Pneumologie, 77(S 01), p S45.
C. Bal, et al., “The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy”, Pneumologie, vol. 77, 2023, pp. S45.
Bal, C., Korn, S., Milger-Kneidinger, K., Skowasch, D., Schulz, C., Zehetmayer, S., Taube, C., Hamelmann, E., Buhl, R., Idzko, M.: The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy. Pneumologie. 77, S45 (2023).
Bal, C., Korn, S., Milger-Kneidinger, K., Skowasch, D., Schulz, C., Zehetmayer, S., Taube, C., Hamelmann, Eckard, Buhl, R., and Idzko, M. “The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy”. Pneumologie 77.S 01 (2023): S45.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar